PGx Medication Safety Reviews of Persons With IDD
PGx Medication Safety Reviews of Persons With IDD
Not yet recruiting · NCT07092852 · Registry updated 2025-07-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PGx Medication Safety Reviews of Persons With IDD | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, developmental disability, follicular lymphoma, immune system disorder, immunoproliferative disorder, intellectual disability, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, nervous system disorder, neurodevelopmental disorder, psychiatric disorder | Not yet recruiting | Not stated | 2025-07-30 | NCT07092852 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CP Unlimited | 1 |
| GalenusRx, Inc. | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CP Unlimited | The Bronx | United States | 1 |
| GalenusRx, Inc. | Montverde | United States | 1 |